Wysenski Nancy has filed 28 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 98 shares of CYTOKINETICS INC ($CYTK) on January 15, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 98 | $63.44 | 30,971.0000 | 122,264,929 | 0.32% | 0.00% |
| Oct. 15, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 99 | $62.80 | 30,873.0000 | 118,410,689 | 0.32% | 0.00% |
| July 15, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 164 | $38.01 | 30,774.0000 | 118,410,689 | 0.54% | 0.00% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 7333 | $0.00 | 30,610.0000 | 118,410,689 | 31.50% | 0.01% |
| April 15, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 162 | $38.56 | 23,277.0000 | 118,410,689 | 0.70% | 0.00% |
| Jan. 2, 2025 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 127 | $48.93 | 23,115.0000 | 0 | 0.55% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 118 | $52.60 | 22,988.0000 | 0 | 0.52% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 114 | $0.00 | 22,870.0000 | 0 | 0.50% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 5600 | $0.00 | 22,756.0000 | 0 | 32.64% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 74 | $84.12 | 17,156.0000 | 0 | 0.43% | 0.00% |
| Oct. 2, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 224 | $27.88 | 17,082.0000 | 0 | 1.33% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Restricted Stock Unit Award | 5957 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | F | Ordinary Shares | 1430 | $29.88 | 31,598.0000 | 163,742,000 | 4.33% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Ordinary Shares | 5957 | $0.00 | 33,028.0000 | 163,742,000 | 22.01% | 0.00% |
| July 3, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 187 | $33.36 | 16,858.0000 | 0 | 1.12% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | A | Restricted Stock Unit Award | 5985 | $0.00 | 5,985.0000 | 163,742,000 | 9999.99% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | A | Non Qualified Stock Option (Right to Buy) | 12732 | $0.00 | 12,732.0000 | 163,742,000 | 9999.99% | 0.01% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 5000 | $0.00 | 16,671.0000 | 0 | 42.84% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 9, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Ordinary Shares | 35000 | $31.13 | 62,071.0000 | 163,742,000 | 129.29% | 0.02% |
| May 9, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Ordinary Shares | 6250 | $31.13 | 68,321.0000 | 163,742,000 | 10.07% | 0.00% |
| May 9, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | S | Ordinary Shares | 41250 | $31.24 | 27,071.0000 | 163,742,000 | 60.38% | 0.03% |
| May 9, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Non Qualified Stock Option (Right to Buy) | 6250 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.00% |
| May 9, 2023 | Alkermes plc. | $ALKS | Wysenski Nancy | Director | M | Non Qualified Stock Option (Right to Buy) | 35000 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.02% |
| April 3, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 149 | $37.71 | 11,671.0000 | 0 | 1.29% | 0.00% |
| Jan. 3, 2023 | CYTOKINETICS INC | $CYTK | Wysenski Nancy | Director | A | Common Stock | 126 | $44.35 | 11,522.0000 | 0 | 1.11% | 0.00% |